Currarino Moyano Giancarlo 4
4 · OWENS ILLINOIS INC /DE/ · Filed Mar 11, 2019
Insider Transaction Report
Form 4
Currarino Moyano Giancarlo
SVP, Chief Tech & SC Officer
Transactions
- Award
Common Stock (Direct)
2019-03-07+12,264→ 75,772 total - Sale
Common Stock (Direct)
2019-03-07$19.74/sh−9,371$185,029→ 77,430 total - Sale
Common Stock (Direct)
2019-03-07$20.10/sh−11,295$226,991→ 66,135 total - Exercise/Conversion
Common Stock (Direct)
2019-03-07$17.78/sh+1,104$19,629→ 88,171 total - Sale
Common Stock (Direct)
2019-03-07$20.10/sh−1,104$22,187→ 86,801 total - Exercise/Conversion
Stock Option 03/07/2016 $15.05
2019-03-07−11,295→ 5,647 totalExercise: $15.05From: 2017-03-07Exp: 2023-03-07→ Common Stock (Direct) (11,295 underlying) - Award
Common Stock (Direct)
2019-03-07+35,524→ 63,508 total - Sale
Common Stock (Direct)
2019-03-07$20.10/sh−266$5,346→ 87,905 total - Exercise/Conversion
Common Stock (Direct)
2019-03-07$15.05/sh+11,295$169,990→ 87,067 total - Sale
Common Stock (Direct)
2019-03-07$19.52/sh−35,524$693,482→ 30,611 total - Exercise/Conversion
Stock Option 09/01/16 $17.78
2019-03-07−1,104→ 2,208 totalExercise: $17.78From: 2017-09-01Exp: 2023-09-01→ Common Stock (Direct) (1,104 underlying)
Holdings
- 898.416(indirect: By 401(k))
Common Stock (Indirect)
Footnotes (7)
- [F1]Certain restricted stock units granted for the 2016-2018 grant period vest in the form of common stock based upon the Issuer's performance against certain strategic objective goals. On March 7, 2019, the Compensation Committee of the Issuer's Board of Directors determined that the strategic objective goals had been met, resulting in the vesting of these shares.
- [F2]The restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.89 to $20.24, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.70 to $19.895, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.44 to $19.64, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, March 7, 2017.
- [F7]The options become exercisable in annual 25% increments beginning on the first anniversary of the grant date, September 1, 2017.